Published in Health and Medicine Week, May 22nd, 2000
COPD, which affects lung function, occurs predominantly in tobacco smokers and is a leading cause of illness and death worldwide. As lung function deteriorates (measured by forced expiratory volume - FEV) substantial changes in general health occur.
Dr. Peter Burge and colleagues report in the British Medical Journal on the ISOLDE trial in which 18 U.K. hospitals took part involving 751 patients who were current or former smokers. The men and women were aged between 40 and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.